PE4S267 - Hormone Replacement Therapy 01 Sep 2024 - 31 Aug 2030 | Version 2

Associated Module Information

Module Code: PE4S267
Module Title: Hormone Replacement Therapy
Faculty: Faculty of Life Sciences and Education
Faculty Group: FLSE Faculty
Faculty Sub Group: Clinical Services
Module Leader:
Module Team: Smita Satpathy, Bhaskara Kale, Neha Gami, Tamseela Ahmed, Haseena Hamdani
First Intended Intake: SEP 2024 Final Year of Intake:
Date Closed:
Credit Value: 20 Credit Level: 7
Language: English
Percentage of Module Taught in Welsh: 0
Equivalent Module:
HECOS codes: 100260 - healthcare science
HECOS Code Weighting: 100

Document Version Information

Version 2
Valid From 01 Sep 2024
Valid To 31 Aug 2030

Module Aims

The aim of this module is to enable participants to develop expertise in hormone replacement therapies (HRT) for the management of menopause. Participants will gain an in-depth understanding of the principles underlying HRT, including its benefits, risks, indications, and contraindications. The module aims to equip healthcare professionals with the knowledge and skills to personalise HRT regimens, monitor patient response, and adjust treatment plans as needed. Participants will critically evaluate the evidence base, pharmacokinetics, and pharmacodynamics of HRT to make informed decisions and optimise patient outcomes.

Content Summary

Indicative content to include topics outlined below and/or any other relevant current topics to fulfil the module aims and learning outcomes:
? Principles of Hormone Replacement Therapy (HRT)
? Indications and Contraindications for HRT
? Personalising HRT Regimens
? Monitoring and Assessment of HRT Efficacy and Safety
? Managing Complications and Side Effects of HRT
? Non-Hormonal Alternatives for Menopausal Management.

Learning and Teaching Methods

Activity Type Hours
Independent Study 100
Directed Study 100
Total Hours Selected 200

Learning Outcomes

# Learning Outcome
LO1 Develop a systematic understanding of the principles underlying hormone replacement therapies (HRT) in menopause management and critically evaluate the benefits and risks of HRT based on the current evidence base.
LO2 Demonstrate an ability to incorporate the knowledge into complex case scenarios relating to menopause medicine, considering appropriate indications and contraindications for HRT, as well as individual patient factors and preferences.

Module Requisites

N/A

Assessment Criteria

Assessment Category Assessment Type Description Duration Word Count Weight (%) Best of? Pass Mark
Synchronous Online Assessment Time-constrained assessment (Online) 1 Assessment to be completed in a specific timescale, which is neither an invigilated examination nor a piece of coursework. To be completed over an extended period (e.g. a 2-hour task to be completed within 48 hours, or a 24-hour assessment).Learna: End of module 1-hour MCQ examination related to Menopause Medicine to be completed within a 10-day period. 60 600 30 No 40
Asynchronous Assessment Self Reflective Assessment 1 A personal record of a student’s learning experiences. It requires students to record and reflect upon their observations and responses to situations, which can then be used later to explore and analyse ways of thinking and being in context. Generally involves critical diaries, learning logs and written / visual journals or Reflective journal 0 600 10 No 40
Asynchronous Assessment Project 1 A detailed analysis of a topic, involving some original research undertaken by the candidate who makes use of data and/or primary sources or Completion of an individual/group task related to the principles and management of hormone replacement therapy. 0 1000 20 No 40
Asynchronous Assessment Case study 1 A concentrated inquiry into a single case or subject or Case-based scenarios and a discussion forum related to the principles and management of hormone replacement therapy. 0 2400 40 No 40

Assessment Matrix

Assessment Type Learning Outcomes
LO1 LO2
Time-constrained assessment (Online) 1
Self Reflective Assessment 1
Project 1
Case study 1

Reading List

Core:

NICE (2015). Overview | Menopause: diagnosis and management | Guidance | NICE. [online] Nice.org.uk. Available at: https://www.nice.org.uk/guidance/ng23.

Journals:

Mariette-JB (n.d.). Post Reproductive Health Journal. [online] British Menopause Society. Available at: https://thebms.org.uk/publications/journal/.

Websites:

GOV.uk (2019) Hormone replacement therapy (HRT): further information on the known increased risk of breast cancer with HRT and its persistence after stopping [online]: https://www.gov.uk/drug-safety-update/hormone-replacement-therapy-hrt-further-information-on-the-known-increased-risk-of-breast-cancer-with-hrt-and-its-persistence-after-stopping

International Menopause Society. (n.d.). Home. [online]. Available at: https://www.imsociety.org/.

British Menopause Society. (n.d.). Home. [online]. Available at: https://thebms.org.uk/

Each module reading list will consist of up-to-date peer-reviewed journal articles and studies that are continually refreshed as guidelines change and new treatments and technologies emerge.

The list is compiled during the authoring of each module to ensure currency.

Additional reading resources are supplemented by the tutors during the running of the module.